Robin Egan, PA
Physician Assistant · Kapolei, HINPI 1972955474
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $764 of the $1,049 with a category attached, or 72.8%. 14 manufacturers reported payments, led by UCB, Inc. at 33.1% of the total. Reporting peaked in 2024 at $690 and has fallen 56.3% since, to $301 in 2025.
Across 47 payments — averaging $22.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$347
- Sun Pharmaceutical Industries Inc.$334
- Sanofi-aventis U.S. LLC$100
- Sanofi$51
- Lilly USA, LLC$37
- E.r. Squibb & Sons, L.L.C.$33
- plus $148 from 8 others
What the payments were for
- Food & beverage$76473%
- Education$28527%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 21 | $347 |
| Sun Pharmaceutical Industries Inc. | 10 | $334 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Sanofi | 3 | $51 |
| Lilly USA, LLC | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Organogenesis Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $19 |
| Amgen | 1 | $18 |
| Biofrontera Inc. | 1 | $17 |
| Pfizer | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Novartis | 1 | $13 |
How this compares
$1,049 in reported general payments places this provider in the 75th percentile of 246 physician assistant providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 30 | $1,279 |
| Fluocinolone Acetonide | 25 | $1,140 |
| Mometasone Furoate | 30 | $617 |
| Clindamycin Phosphate | 18 | $607 |
| Fluocinonide | 17 | $550 |
| Ketoconazole | 33 | $485 |
| Doxycycline Hyclate | 40 | $395 |
| Desonide | 13 | $264 |
| Mupirocin | 22 | $227 |
| Triamcinolone Acetonide | 32 | $149 |
| Minocycline Hcl | 13 | $135 |
| Spironolactone | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Kapolei
- Valerie MarinoKapolei$5K
- Renisse TrillanaKapolei$3K
- Brooke GarciaMililani$381K
- Eric YukumotoHonolulu$41K
- Dorothy MauriceHonolulu$39K
- Patricia AchayKailua Kona$22K
- Marne Carmichael WalshHilo$17K
- Edie HamiltonKahului$13K
- Joycelyn ChunHonolulu$11K
- Rachel InouyeHonolulu$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.